Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Event
NYU's Ambulatory Care Center at 240 East 38th Street, New York, NY, USA
We will be having a joint session with another community group, the alopecia areata group. Alopecia areata is an immune-related disease, like vitiligo, that causes hair loss usually in patches on the scalp and eyebrows.
The meeting will be on:
Thursday, April 13th, 2017 at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Avenues!
Note that as of now, the meeting time has been changed from 6:30 to 7PM
Spread the word and all family and friends are welcome!
Please let us know if you will be able to attend by email nyvitiligo@gmail.com.
We look forward to seeing you all there.
NY Vitiligo Community
FAQOther Questions
- Which therapy has minimal side-effects?
Dead Sea climatotherapy has shown promising results in treating vitiligo in people of all ages. It is considered as the only treatment that’s safe for nearly all vitiligo patien...
- I have vitiligo: will my children have vitiligo, too?
Children born to parents who both have the disorder are more likely to develop vitiligo. However, most children will not get vitiligo even if one parent has it. In children with...
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.